DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

416.66 2.02 (0.49%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

REGN $416.66 0.49%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $410.88
Previous Close $414.64
Daily Range $410.60 - $424.74
52-Week Range $269.50 - $437.64
Market Cap $42.4B
P/E Ratio 140.08
Dividend (Yield) $0.00 (0.0%)
Volume 1,060,824
Average Daily Volume 869,912
Current FY EPS $8.01





Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website:

News & Commentary Rss Feed

5 Tiny Biotech Stocks to Own in 2015

Insys Therapeutics, Achillion Pharmaceuticals, Portola Pharmaceuticals, Ophthotech, and Acceleron Pharma have intriguing pipelines that may make them stocks to own this year.

Protalex Aiming At Rheumatoid Arthritis Market With A Much Cheaper Price Tag

Regeneron/Sanofi's PCSK9 Drug Gets FDA Priority Review - Analyst Blog

Can Celgene (CELG) Beat Earnings on Strong Product Sales? - Analyst Blog

US Stock Futures Signal Lower Start On Wall Street

Health Care Sector Update for 01/23/2015: REGN, ASPX, CELG

The 5 Biggest Biotech Stocks

Today's Momo Momentum Stock Is Regeneron Pharmaceuticals (REGN)

Alexion Pharmaceuticals Proves That Soliris Isn't Immune To Failure

Amgen Will Deliver In 2015

See More REGN News...

REGN's Top Competitors

REGN $416.66 (0.49%)
Current stock: REGN
AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
BIIB $389.16 (10.17%)
Current stock: BIIB